Skip to content
Life sciences job report shows growth slowing, but firms still invest in talent
As the United States has long been a life sciences leader, the health ...
Read More
Protect IP protections, BIO 2025 panel urges
Given the essential role that intellectual property plays in the development of lifesaving ...
Read More
BIO 2025: The urgent need to address AMR and cancer
As antimicrobial resistance (AMR) continues to threaten global public health, its impact on ...
Read More
BIO expert explains patents at DOJ and FTC listening session
Patents enable the innovation that produces new lifesaving treatments while ensuring a competitive ...
Read More
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally ...
Read More
Onerous reporting requirements crushing small biotechs, BIO Board member testifies
Even if they aren’t making revenue, small biotechs can face onerous reporting requirements ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
Bioeconomy
Life sciences job report shows growth slowing, but firms still invest in talent
As the United States has long been a life sciences leader, the health of the life sciences sector is a pretty good indicator of overall ...
BIO Events
Protect IP protections, BIO 2025 panel urges
Given the essential role that intellectual property plays in the development of lifesaving scientific advances, we need to defend and strengthen policy that protects IP, ...
BIO Events
BIO 2025: The urgent need to address AMR and cancer
As antimicrobial resistance (AMR) continues to threaten global public health, its impact on cancer patients is a growing, often overlooked crisis. Patients with cancer are ...
Federal Policy
BIO expert explains patents at DOJ and FTC listening session
Patents enable the innovation that produces new lifesaving treatments while ensuring a competitive market, the top IP expert for the Biotechnology Innovation Organization (BIO) told ...
BIO Events
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
Life sciences job report shows growth slowing, but firms still invest in talent
As the United States has long been a life sciences leader, the health of the life sciences sector is a ...
Read More
International
Bio's View
Onerous reporting requirements crushing small biotechs, BIO Board member testifies
Even if they aren’t making revenue, small biotechs can face onerous reporting requirements that cost $1 million or more, cutting ...
Read More
